BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18314065)

  • 1. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
    Nuyten DS; van de Vijver MJ
    Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical review of microarray-based prognostic tests and trials in breast cancer.
    Koscielny S
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):47-50. PubMed ID: 18197005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer bone metastasis: molecular basis of tissue tropism.
    Kang Y
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microarray technology--potential in cancer research].
    Forus A; Sørlie T; Børresen-Dale AL; Myklebost O
    Tidsskr Nor Laegeforen; 2001 Sep; 121(21):2498-503. PubMed ID: 11875927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling: decoding breast cancer.
    de Snoo F; Bender R; Glas A; Rutgers E
    Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
    Weigelt B; Baehner FL; Reis-Filho JS
    J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer gene microarrays pass muster.
    Twombly R
    J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple gene signatures aim to qualify risk in breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2005 Mar; 97(5):332. PubMed ID: 15741566
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-expression profiling in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Cannistra SA
    Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer.
    Thomassen M; Tan Q; Eiriksdottir F; Bak M; Cold S; Kruse TA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5355-60. PubMed ID: 17875763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.